SURURAT COULIBALY: Open Payments
NPI 1235427816 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66 in 3 payments from 3 companies in 2025. Trend: 2023 $3,154 · 2024 $1,426 · 2025 $66
Food & beverage: $66
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $34 |
| Boston Scientific Corporation | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: General - Pain Management, Sotyktu.
Industry payments across NV — which companies pay providers there.
